Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa

Gynecologic Oncology

Volumn 61, Issue 3, 1996, Pages 309-314

  Cass, I ^a   Resnik, E ^a   Chambers, J T ^a   Chambers, S K ^a   Carcangiu, M L ^a   Kohorn, E I ^a   Schwartz, P E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE;

ADNEXA DISEASE; ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MUELLERIAN DUCT; NEPHROTOXICITY; OVARY CARCINOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE TUBE CARCINOMA;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MIXED TUMOR, MULLERIAN; OVARIAN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0029941560     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0148     Document Type: Article

References (34)

1. Pfeiffer, P., Hardt-Madsen, M., Rex, S., Holund, B., and Bertelsen, K. Malignant mixed mullerian tumors of the ovary, Acta Obstet. Gynecol. Scand. 70, 79-83 (1991).
2. Morrow, C. P., d'Ablaing, G., Brady, L. W., Blessing, J. A., and Hreshchyshyn, M. M. A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: A Gynecologic Oncology Group study, Gynecol. Oncol. 18, 278-292 (1984).
3. Hanjani, P., Petersen, R. O., Lipton, S. E., and Nolte, S. A. Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: Report of eight cases and review of literature, Obstet. Gynecol. Survey 38, 537-545 (1983).
4. Hernandez, W., DiSaia, P., Morrow, C. P., and Townsend, D. E. Mixed mesodermal sarcoma of the ovary, Obstet. Gynecol. 49, 59S-63S (1977).
5. Morrow, C. P., Bundy, B. N., Hoffman, J., Sutton, G., and Homesley, H. Adriamycin chemotherapy for malignant mixed mesodermal tumor of the ovary: A Gynecologic Oncology Group study, Am. J. Clin. Oncol. 9, 24-26 (1986).
6. Baker, T. R., Piver, M. S., Caglar, H., and Piedmonte, M. Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovary, Am. J. Clin. Oncol. 14, 246-250 (1991).
7. Andersen, W. A., Young, D. E., Peters, W. A., Smith, E. B., Bagley, C. M., and Taylor, P. T. Platinum-based combination chemotherapy for malignant mixed mesodermal tumors of the ovary, Gynecol. Oncol. 32, 319-322 (1989).
8. Plaxe, S. C., Dottino, P. R., Goodman, H. M., Deligdisch, L., Idelson, M., and Cohen, C. J. Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin and cis-platinum-based chemotherapy, Gynecol. Oncol. 37, 244-249 (1990).
9. Smith, J. P., and Rutledge, F. Advances in chemotherapy for gynecologic cancer, Cancer 36, 669-674 (1975).
10. Grosh, W. W., Jones, H. W., Burnett, L. S., and Greco, F. A. Malignant mesodermal tumors of the uterus and ovary treated with cisplatin-based combination chemotherapy, Gynecol. Oncol. 25, 334-339 (1986).
11. Thigpen, J. T., Blessing, J. A., Beecham, J., Homesley, H., and Yordan, E. Phase II trial of cisplatin as first line chemotherapy in patients with advanced or recurrent uterine sarcomas: A Gynecologic Oncology Group Study, J. Clin. Oncol. 9, 1962-1966 (1991).
12. Schabel, F. M., Jr., Trader, M. W., Laster, W. R., Corbett, T. H. and Griswold, D. P., Jr. cis-Dichchlorodiamieplatinum(II): Combination chemotherapy and cross-resistance studies with tumors of mice, Cancer Treat. Rep. 63, 1459-1473 (1987).
13. Tsai, C., Gazdar, A. F., Venzon, D. J., Steinberg, S. M., Dedrick, R. L., Mulshine, J. L., and Kramer, B. S. Lack of in vitro synergy between etoposide and cis-diammine-dichloroplatinum(II), Cancer Res. 49, 2390-2397 (1989).
14. Muggia, F. M., and Russell, C. A. New chemotherapies for ovarian cancer, Cancer 67, 225-230 (1991).
15. Resnik, E., Chambers, S. K., Carcangiu, M. L., Kohorn, E. I., Schwartz, P. E., and Chambers, J. T. Etoposide, cisplatin and doxorubicin chemotherapy in mixed mullerian tumors of the uterus, Gynecol. Oncol. 56, 370-375 (1995).
16. DCI/NCI common toxicity criteria, July 1989, pp. 6-9.
17. Carlson, J. A., Edwards, C., Wharton, J. T., Gallager, H. S., Delclos, L., and Rutledge, F. Mixed mesodermal sarcoma of the ovary, Cancer 52, 1473-1437 (1983).
18. Deppe, G., Zbella, E., Friberg, J., and Thomas, W. Combination chemotherapy for mixed mullerian tumor of the fallopian tube, Cancer 54, 1517-1520 (1984).
19. Lele, S. B., Piver, M. S., and Barlow, J. J. Chemotherapy in the management of mixed mesodermal tumors of the ovary, Gynecol. Oncol. 10, 298-302 (1980).
20. Dictor, M. Malignant mixed mesodermal tumor of the ovary: A report of 22 cases, Obstet. Gynecol. 65, 720-724 (1985).
21. Barakat, R. R., Rubin, S. C., Wong, G., Saigo, P. E., Markman, M., and Hoskins, W. J. Mixed mullerian tumor of the ovary: Analysis of prognostic factors in 31 cases, Obstet. Gynecol. 80, 660-664 (1992).
22. DiSaia, P., Castro, J. R., and Rutledge, F. N. Mixed mesodermal sarcoma of the uterus, Am. J. Roentgenol. 117, 632-636 (1973).
23. Blum, R. H. An overview of studies with adriamycin (NSC-123127) in the United States, Cancer Chemother. Rep. 6, 246-251 (1975).
24. Gottlieb, J. A., Baker, L. H., and O'Bryan, R. M. Adriamycin (NSC-123127) used alone, and in combination for soft tissue and bony sarcomas, Cancer Treat. Rep. 6, 271-282 (1975).
25. Yap, B. S., Baker, L. H., Sinkovics, J. G., Rivkin, S. E., Bottomley, R., Thigpen, T., Burgess, M. A., Benjamin, R. S., and Bodey, G. P. Cyclophosphamide, vincristine, adriamycin and DTIC (CY-VADIC) combination chemotherapy for the treatment of advanced sarcomas, Cancer Treat. Rep. 64, 93-98 (1980).
26. Blum, R. H., Corson, J. M., Wilson, R. E., Greenberger, J. S., Canellos, G. P., and Frei, E., 3d. Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin and DTIC (CAD), Cancer 46, 1722-1726 (1980).
27. Rosenbaum, C., and Schoenfeld, D. Treatment of advanced soft tissue sarcomas Proc. AACR/ASCO 18, 287 (1977).
28. Gottlieb, J. A., Bodey, G. P., Sinkovics, J. G., Rodriguez, V., and Burgess, M. A. An effective new 4 drug combination regimen (CT-VA-DIC) for metastatic sarcomas, Proc. ASCO 15, (1974).
29. Omura, G. A., Major, F. J., Blessing, J. A., Sedlacek, T. V., Thigpen, J. T., Creasman, W. T., and Zaino, R. J. A randomized study of adriamycin with and without dimethyl triazenimidazole carboxamide in advanced uterine sarcomas, Cancer 52, 626-632 (1983).
30. Piver, M. S., Barlow, J. J., Lele, S. B., and Yagizi, R. Adriamycin in localized and metastatic uterine sarcomas, J. Surg. Oncol. 12, 263-265 (1979).
31. Piver, M. S., Lele, S. B., and Patsner, B. cis-Diamminedichloroplatinum plus dimethyl-triazenoimidazole carboxamide as second and third-line chemotherapy for sarcomas of the female pelvis, Gynecol. Oncol. 23, 371-375 (1986).
32. Karakousis, C. P., Holtermann, O. A., and Holyoke, E. D. cis-Dichlorodiammine platinum(II) in metastatic soft tissue sarcomas, Cancer Treat. Rep. 63, 2071 (1979).
33. Wheelock, J., Hancock, K., and Smith, K. Cisplatin, doxorubicin, and cyclophosphamide (PAC) in the treatment of mixed mesodermal tumor of the ovary, Cancer Treat. Rep. 71, 1275-1276 (1987).
34. Durand, R. E., and Goldie, J. H. Interaction of etoposide and cisplatin in an in vitro model, Cancer Treat. Rep. 71, 673-679 (1987).